217 related articles for article (PubMed ID: 12003183)
41. PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.
Gong FR; Wu MY; Shen M; Zhi Q; Xu ZK; Wang R; Wang WJ; Zong Y; Li ZL; Wu Y; Zhou BP; Chen K; Tao M; Li W
Oncotarget; 2015 Jul; 6(21):18469-83. PubMed ID: 26053095
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge.
Thaqi A; Scott JL; Gilbert J; Sakoff JA; McCluskey A
Eur J Med Chem; 2010 May; 45(5):1717-23. PubMed ID: 20153915
[TBL] [Abstract][Full Text] [Related]
43. The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability.
Knapp J; Bokník P; Lüss I; Huke S; Linck B; Lüss H; Müller FU; Müller T; Nacke P; Noll T; Piper HM; Schmitz W; Vahlensieck U; Neumann J
J Pharmacol Exp Ther; 1999 Jun; 289(3):1480-6. PubMed ID: 10336542
[TBL] [Abstract][Full Text] [Related]
44. Effects of phosphoprotein phosphatase inhibitors (phenylarsine oxide and cantharidin) on Tetrahymena.
Kovács P; Pintér M
Cell Biochem Funct; 2001 Sep; 19(3):197-205. PubMed ID: 11494309
[TBL] [Abstract][Full Text] [Related]
45. Cantharidin inhibits cell proliferation and induces apoptosis through G2/M phase cell cycle arrest in hepatocellular carcinoma stem cells.
Le AP; Zhang LL; Liu W; Shi YF
Oncol Rep; 2016 May; 35(5):2970-6. PubMed ID: 26986084
[TBL] [Abstract][Full Text] [Related]
46. Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways.
Huang WW; Ko SW; Tsai HY; Chung JG; Chiang JH; Chen KT; Chen YC; Chen HY; Chen YF; Yang JS
Int J Oncol; 2011 Apr; 38(4):1067-73. PubMed ID: 21271215
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity.
Stewart SG; Hill TA; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Dec; 15(23):7301-10. PubMed ID: 17870547
[TBL] [Abstract][Full Text] [Related]
48. Cell cycle-dependent regulation of telomerase activity by auxin, abscisic acid and protein phosphorylation in tobacco BY-2 suspension culture cells.
Yang SW; Jin E; Chung IK; Kim WT
Plant J; 2002 Mar; 29(5):617-26. PubMed ID: 11874574
[TBL] [Abstract][Full Text] [Related]
49. Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo.
Erdödi F; Tóth B; Hirano K; Hirano M; Hartshorne DJ; Gergely P
Am J Physiol; 1995 Nov; 269(5 Pt 1):C1176-84. PubMed ID: 7491907
[TBL] [Abstract][Full Text] [Related]
50. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
51. Cantharidin-based small molecules as potential therapeutic agents.
Puerto Galvis CE; Vargas Méndez LY; Kouznetsov VV
Chem Biol Drug Des; 2013 Nov; 82(5):477-99. PubMed ID: 23809227
[TBL] [Abstract][Full Text] [Related]
52. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
[TBL] [Abstract][Full Text] [Related]
53. Cantharidin-binding protein: identification as protein phosphatase 2A.
Li YM; Casida JE
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11867-70. PubMed ID: 1334551
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation.
Hsieh FS; Hung MH; Wang CY; Chen YL; Hsiao YJ; Tsai MH; Li JR; Chen LJ; Shih CT; Chao TI; Chen KF
Lung Cancer; 2017 Oct; 112():81-89. PubMed ID: 29191605
[TBL] [Abstract][Full Text] [Related]
55. Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg
Assis LC; de Castro AA; Prandi IG; Mancini DT; de Giacoppo JOS; Savedra RML; de Assis TM; Carregal JB; da Cunha EFF; Ramalho TC
J Mol Model; 2018 Oct; 24(10):303. PubMed ID: 30280322
[TBL] [Abstract][Full Text] [Related]
56. Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
Yu CW; Li KK; Pang SK; Au-Yeung SC; Ho YP
Bioorg Med Chem Lett; 2006 Mar; 16(6):1686-91. PubMed ID: 16386904
[TBL] [Abstract][Full Text] [Related]
57. Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin).
Baba Y; Hirukawa N; Tanohira N; Sodeoka M
J Am Chem Soc; 2003 Aug; 125(32):9740-9. PubMed ID: 12904040
[TBL] [Abstract][Full Text] [Related]
58. Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation.
Zhang X; Lin CC; Chan WK; Liu KL; Yang ZJ; Zhang HQ
Molecules; 2017 Jun; 22(7):. PubMed ID: 28672816
[TBL] [Abstract][Full Text] [Related]
59. Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA.
Shen M; Wu MY; Chen LP; Zhi Q; Gong FR; Chen K; Li DM; Wu Y; Tao M; Li W
Sci Rep; 2015 Jul; 5():11836. PubMed ID: 26135631
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional responses to cantharidin, a protein phosphatase inhibitor, in Arabidopsis thaliana reveal the involvement of multiple signal transduction pathways.
Bajsa J; Pan Z; Duke SO
Physiol Plant; 2011 Oct; 143(2):188-205. PubMed ID: 21668865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
